Fixed Drug Eruption and Intradermal Provocation tests

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 12, 2008, Pages 736-739

  Mahboob, Atiya ^a   Haroon, Tahir Saeed ^b   Iqbal, Zafar ^a   Saleemi, Munir Akhtar ^b   Munir, Asma ^b  

^a Shaikh Zayed FPGMI ^*  (Pakistan)

^b KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Erythema; Fixed drug eruption; Intradermal Provocation test; Nodule

Indexed keywords

COTRIMOXAZOLE; DIPYRONE; METRONIDAZOLE; OXYTETRACYCLINE; PHENYLBUTAZONE;

ADULT; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; DRUG MONITORING; DRUG RESPONSE; DRUG SAFETY; FEMALE; FIXED DRUG ERUPTION; HUMAN; HYPERPIGMENTATION; INJECTION SITE BLEEDING; INJECTION SITE ERYTHEMA; INJECTION SITE NODULE; INJECTION SITE URTICARIA; INTRADERMAL PROVOCATION TEST; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; PRURITUS; SKIN TEST;

ADULT; DRUG ERUPTIONS; FEMALE; HUMANS; INTRADERMAL TESTS; MALE;

EID: 59849128904     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Breathnach SM. Drug reactions. In: Champion RH, Burton JH, Ebling FJG, (edi). Rook/Wilkinson/Ebling textbook of dermatology. 7th ed. London: Blackwell Scientific Publications, 2004; 28-9:172-3.
2. Sehgal VN, Gangwani OP. Fixed drug eruption. Current concepts. Int J Dermatol 1987; 26:67-74.
3. Korkij W, Soltani K. Fixed drug eruption: a brief review. Arch Dermatol 1984; 120:520-4.
4. Kanwar AJ, Bharija SC, Singh M, Belhaj MS. Ninety eight fixed drug eruptions with provocation test. Dermatologica 1998; 177: 274-9.
5. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005: 152:968-74.
6. Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116:561-7.
7. Mahboob A, Haroon TS, Iqbal Z, Iqbal F, Saleemi MA, Munir A. Fixed drug eruption: topical provocation and subsequent phenomena. J Coll Physicians Surg Pak 2006; 16:747-50.
8. Ozkaya-Bayazit E. Topical provocation in fixed drug eruption due to metamizol and naproxen. Clin Exp Dermatol 2004; 29: 419-22.
9. Tornero P, De Barrio M, Baeza ML, Herrero T. Cross - reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing. Contact Dermatitis 2004; 51: 57-62.
10. McKay SP, Meslemani D, Stachler RJ, Krouse JH. Intradermal positivity after negative prick testing for inhalants. Otolaryngol Head Neck Surg 2006; 135:232-5.
11. Peltier J, Ryan MW. Comparison of intradermal dilutional testing with the multi-test, II applicator, in testing for mold allergy. Otolaryngol Head Neck Surg 2006; 134:240-4.
12. Cantani A, Micera M. The prick by prick test is safe and reliable in 58 children with atopic dermatitis and food allergy. Eur Rev Med Pbarmacol Sci 2006; 10:115-20.
13. Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH. Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis 2005; 53:335-8.
14. Stranahan D, Rausch D, Deng A, Gaspari A. The role of intradermal skin testing and patch testing in the diagnosis ot autoimmune progesterone dermatitis. Dermatitis 2006; 17:39-42.
15. Brown SG. Fixed eruption in deeply pigmented subjects: clinical observations on 350 patients. Br Med J 1964; 2:1041-4.
16. Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37:833-8.
17. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G. Drug related clinical pattern in fixed drug eruption. Eur J Dermatol 2000; 10: 288-91.
18. Thankappan TP, Zachariah J. Drug-specific clinical pattern in fixed drug eruptions. Int J Dermatol 1991; 30:867-70.